Moolec Science SA(MLEC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 72.45% | Shs Outstand | 0.3M | Perf Week | -10.36% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.2M | Perf Month | -27.61% |
| Enterprise Value | 0.07B | PEG | - | EPS next Q | - | Inst Own | 0.07% | Short Float | 4.46% | Perf Quarter | -39.06% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.57 | Perf Half Y | -29.01% |
| Sales | - | P/B | 0.39 | EPS next 5Y | - | ROA | - | Short Interest | 0.01M | Perf YTD | 29.09% |
| Book/sh | 12.7 | P/C | 3.32 | EPS past 3/5Y | -583.54% -583.54% | ROE | - | 52W High | -78.77% ($23.22) | Perf Year | -71.17% |
| Cash/sh | 1.49 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 60.25% ($3.08) | Perf 3Y | -98.93% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -24.98% | Gross Margin | - | Volatility(W/M) | 14.3% 10.65% | Perf 5Y | -99.67% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.71 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.08 | EPS Q/Q | -32.08% | Profit Margin | - | RSI (14) | 33.49 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.15 | Sales Q/Q | 948.32% | SMA20 | -23.18% ($6.42) | Beta | 0.3 | Target Price | $450 |
| Payout | - | Debt/Eq | 7.21 | Earnings | - | SMA50 | -28.11% ($6.86) | Rel Volume | 0.71 | Prev Close | $5.6 |
| Employees | 103 | LT Debt/Eq | 1.3 | EPS/Sales Surpr. | -16.67% 29.32% | SMA200 | -34.02% ($7.47) | Avg Volume(3M) | 0.02M | Price | $4.93 |
| IPO | 2021/3/2 | Option/Short | No/Yes | Trades | 126 | Volume | 11,133 | Change | -11.96% |
🌱 Molex Science() is a Luxembourg-based food tech company that holds molecular farming technology to produce animal proteins from plants. It develops products such as POORK+, which expresses pork protein in soybeans, and Chymosin SPC, a cheese coagulating enzyme, and is currently pushing to integrate agricultural bio group Bioceres() to restructure its business.
Over the past 1 year, on the lower side
79% below its 1-year high.
Traded less than usual That is 71% of its average volume.
Holding long would have lost money
Bought 5 years ago, your return today would be -99.7%. The S&P 500 did +77% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 0.1%.
Tap to view numbers
It ranks #564 of 592 in the industry
Based on market cap of $4M.
VIVS#563 VivoSim Labs Inc $4M PER - MLEC#564 Moolec Science SA $4M PER - 
GOVX#565 Geovax Labs Inc $4M PER - 
APVO#566 Aptevo Therapeutics Inc $3M PER - 
REVB#567 Revelation Biosciences Inc $3M PER - 
FAQ
What kind of company is MLEC?
MLEC belongs to the Healthcare sector and operates in the Biotechnology industry.
What is the market cap of MLEC?
The market cap of MLEC is approximately $4M, ranking 5,757 within its sector.
What is the 52-week high and low for MLEC?
MLEC has recorded a 52-week high of $23.22 and a low of $3.08.
